Skip to main content
Erschienen in: Supportive Care in Cancer 10/2021

18.03.2021 | Original Article

The financial coping strategies of US cancer patients and survivors

verfasst von: Meredith Doherty, Daniel Gardner, Jackie Finik

Erschienen in: Supportive Care in Cancer | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Coping behaviors may play a mediating role in producing the negative health outcomes observed in financially burdened cancer patients and survivors.

Methods

Exploratory factor and latent class analysis of survey data.

Results

A total of 510 people completed the survey, ages ranged from 25 to over 75 [over half greater than 55 years old (57.8%)]. Most respondents identified as female (64.7%), white (70.8%), or African American (18.6%). A four-factor model of financial coping was revealed: care-altering, lifestyle-altering, self-advocacy, and financial help-seeking. Respondents grouped into three financial coping classes: low burden/low coping (n = 212), high self-advocacy (n = 143), and high burden/high coping (n = 155). African American respondents were at far greater odds than white respondents of being in the high burden/high coping class (OR = 5.82, 95% CI 3.01–6.64) or the self-advocacy class (OR = 1.99, 95% CI 1.19–2.80) than the low burden/low coping class. Compared to respondents aged 65 years and older, those 35–44 were more likely in the high burden/high coping class (OR = 12.27, 95% CI 7.03–19.87) and the high self-advocacy class (OR = 7.08, 95% CI 5.89–8.28) than the low burden/low coping class.

Conclusion

One-third of respondents were in the high burden/high coping class. Age and race/ethnicity were significantly associated with class membership. Some coping strategies may compromise health and well-being. Program and policy interventions that reduce the odds that patients will use strategies that undermine treatment outcomes and increase patient use of protective strategies are needed.
Literatur
1.
Zurück zum Zitat Gilligan AM, Alberts DS, Roe DJ, Skrepnek GH (2018) Death or debt? National estimates of financial toxicity in persons with newly-diagnosed cancer. Am J Med 131(10):1187–1199PubMedCrossRef Gilligan AM, Alberts DS, Roe DJ, Skrepnek GH (2018) Death or debt? National estimates of financial toxicity in persons with newly-diagnosed cancer. Am J Med 131(10):1187–1199PubMedCrossRef
2.
Zurück zum Zitat Fenn KM, Evans SB, McCorkle R, DiGiovanna MP, Pusztai L, Sanft T et al (2014) Impact of financial burden of cancer on survivors’ quality of life. J Oncol Pract 10(5):332–338PubMedCrossRef Fenn KM, Evans SB, McCorkle R, DiGiovanna MP, Pusztai L, Sanft T et al (2014) Impact of financial burden of cancer on survivors’ quality of life. J Oncol Pract 10(5):332–338PubMedCrossRef
3.
Zurück zum Zitat Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D (2015) Population-based assessment of cancer survivors’ financial burden and quality of life: a prospective cohort study. J Oncol Pract 11(2):145–150PubMedCrossRef Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D (2015) Population-based assessment of cancer survivors’ financial burden and quality of life: a prospective cohort study. J Oncol Pract 11(2):145–150PubMedCrossRef
4.
Zurück zum Zitat Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL (2014) Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol 32(4):306–311PubMedCrossRef Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL (2014) Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol 32(4):306–311PubMedCrossRef
5.
Zurück zum Zitat Neugut AI, Subar M, Wilde ET, Stratton S, Brouse CH, Hillyer GC, Grann VR, Hershman DL (2011) Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol 29(18):2534–2542PubMedPubMedCentralCrossRef Neugut AI, Subar M, Wilde ET, Stratton S, Brouse CH, Hillyer GC, Grann VR, Hershman DL (2011) Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol 29(18):2534–2542PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D (2016) Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J Clin Oncol 34(15):1732–1740PubMedPubMedCentralCrossRef Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D (2016) Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J Clin Oncol 34(15):1732–1740PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Holland JC, Andersen B, Breitbart WS, Compas B, Dudley MM, Fleishman S et al (2010) Distress management. J Natl Compr Cancer Netw 8(4):448–485CrossRef Holland JC, Andersen B, Breitbart WS, Compas B, Dudley MM, Fleishman S et al (2010) Distress management. J Natl Compr Cancer Netw 8(4):448–485CrossRef
8.
Zurück zum Zitat Meeker CR, Geynisman DM, Egleston BL, Hall MJ, Mechanic KY, Bilusic M, Plimack ER, Martin LP, von Mehren M, Lewis B, Wong YN (2016) Relationships among financial distress, emotional distress, and overall distress in insured patients with cancer. J Oncol Pract 12(7):e755–e764PubMedPubMedCentralCrossRef Meeker CR, Geynisman DM, Egleston BL, Hall MJ, Mechanic KY, Bilusic M, Plimack ER, Martin LP, von Mehren M, Lewis B, Wong YN (2016) Relationships among financial distress, emotional distress, and overall distress in insured patients with cancer. J Oncol Pract 12(7):e755–e764PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Ramsey SD, Bansal A, Fedorenko CR, Blough DK, Overstreet KA, Shankaran V, Newcomb P (2016) Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol 34(9):980–986PubMedPubMedCentralCrossRef Ramsey SD, Bansal A, Fedorenko CR, Blough DK, Overstreet KA, Shankaran V, Newcomb P (2016) Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol 34(9):980–986PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Zafar YS (2016) Financial toxicity of cancer care: it’s time to intervene. J Natl Cancer Instit 108(5):djv370CrossRef Zafar YS (2016) Financial toxicity of cancer care: it’s time to intervene. J Natl Cancer Instit 108(5):djv370CrossRef
11.
Zurück zum Zitat Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR (2017) Financial hardships experienced by cancer survivors: a systematic review. JNCI: J Natl Cancer Instit 109(2):djw205CrossRef Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR (2017) Financial hardships experienced by cancer survivors: a systematic review. JNCI: J Natl Cancer Instit 109(2):djw205CrossRef
12.
Zurück zum Zitat Jagsi R, Pottow JA, Griffith KA, Bradley C, Hamilton AS, Graff J et al (2014) Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol 32(12):1269–1276PubMedPubMedCentralCrossRef Jagsi R, Pottow JA, Griffith KA, Bradley C, Hamilton AS, Graff J et al (2014) Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol 32(12):1269–1276PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Bestvina CM, Zullig LL, Rushing C, Chino F, Samsa GP, Altomare I et al (2014) Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract 10(3):162–167PubMedCrossRef Bestvina CM, Zullig LL, Rushing C, Chino F, Samsa GP, Altomare I et al (2014) Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract 10(3):162–167PubMedCrossRef
14.
Zurück zum Zitat Kent EE, Forsythe LP, Yabroff KR, Weaver KE, de Moor JS, Rodriguez JL, Rowland JH (2013) Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer 119(20):3710–3717PubMedCrossRef Kent EE, Forsythe LP, Yabroff KR, Weaver KE, de Moor JS, Rodriguez JL, Rowland JH (2013) Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer 119(20):3710–3717PubMedCrossRef
15.
Zurück zum Zitat Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, Abernethy AP (2013) The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist 18(4):381–390PubMedPubMedCentralCrossRef Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, Abernethy AP (2013) The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist 18(4):381–390PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Huntington SF, Weiss BM, Vogl DT, Cohen AD, Garfall AL, Mangan PA, Doshi JA, Stadtmauer EA (2015) Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol 2(10):e408–e416PubMedCrossRef Huntington SF, Weiss BM, Vogl DT, Cohen AD, Garfall AL, Mangan PA, Doshi JA, Stadtmauer EA (2015) Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol 2(10):e408–e416PubMedCrossRef
17.
Zurück zum Zitat Irwin B, Kimmick G, Altomare I, Marcom PK, Houck K, Zafar SY, Peppercorn J (2014) Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist 19(11):1135–1140PubMedPubMedCentralCrossRef Irwin B, Kimmick G, Altomare I, Marcom PK, Houck K, Zafar SY, Peppercorn J (2014) Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist 19(11):1135–1140PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Zullig LL, Peppercorn JM, Schrag D, Taylor DH Jr, Lu Y, Samsa G, ... Zafar SY (2013) Financial distress, use of cost-coping strategies, and adherence to prescription medication among patients with cancer. J Oncol Pract 9(6S)60s–63s Zullig LL, Peppercorn JM, Schrag D, Taylor DH Jr, Lu Y, Samsa G, ... Zafar SY (2013) Financial distress, use of cost-coping strategies, and adherence to prescription medication among patients with cancer. J Oncol Pract 9(6S)60s–63s
19.
Zurück zum Zitat Nipp RD, Zullig LL, Samsa G, Peppercorn JM, Schrag D, Taylor DH Jr, Abernethy AP, Zafar SY (2016) Identifying cancer patients who alter care or lifestyle due to treatment-related financial distress. Psycho-oncology 25(6):719–725PubMedCrossRef Nipp RD, Zullig LL, Samsa G, Peppercorn JM, Schrag D, Taylor DH Jr, Abernethy AP, Zafar SY (2016) Identifying cancer patients who alter care or lifestyle due to treatment-related financial distress. Psycho-oncology 25(6):719–725PubMedCrossRef
20.
Zurück zum Zitat Lazarus RS, Folkman S (1984) Stress, appraisal, and coping. Springer publishing company Lazarus RS, Folkman S (1984) Stress, appraisal, and coping. Springer publishing company
21.
Zurück zum Zitat Folkman S, Lazarus RS (1988) Coping as a mediator of emotion. J Pers Soc Psychol 54(3):466–475PubMedCrossRef Folkman S, Lazarus RS (1988) Coping as a mediator of emotion. J Pers Soc Psychol 54(3):466–475PubMedCrossRef
22.
Zurück zum Zitat CancerCare. (2016). CancerCare patient access and engagement report. CancerCare. CancerCare. (2016). CancerCare patient access and engagement report. CancerCare.
23.
Zurück zum Zitat de Souza JA, Kung S, O’Connor J, Yap BJ (2017) Determinants of patient-centered financial stress in patients with locally advanced head and neck cancer. J Oncol Pract 13(4):e310–e318PubMedCrossRef de Souza JA, Kung S, O’Connor J, Yap BJ (2017) Determinants of patient-centered financial stress in patients with locally advanced head and neck cancer. J Oncol Pract 13(4):e310–e318PubMedCrossRef
24.
Zurück zum Zitat Hastert TA, Banegas MP, Hamel LM, Reed AR, Baird T, Beebe-Dimmer JL, Schwartz AG (2019) Race, financial hardship, and limiting care due to cost in a diverse cohort of cancer survivors. J Cancer Surviv 13(3):429–437PubMedPubMedCentralCrossRef Hastert TA, Banegas MP, Hamel LM, Reed AR, Baird T, Beebe-Dimmer JL, Schwartz AG (2019) Race, financial hardship, and limiting care due to cost in a diverse cohort of cancer survivors. J Cancer Surviv 13(3):429–437PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Hershman DL, Tsui J, Wright JD, Coromilas EJ, Tsai WY, Neugut AI (2015) Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer. J Clin Oncol 33(9):1053–1059PubMedPubMedCentralCrossRef Hershman DL, Tsui J, Wright JD, Coromilas EJ, Tsai WY, Neugut AI (2015) Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer. J Clin Oncol 33(9):1053–1059PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Yabroff KR, Dowling EC, Guy GP Jr, Banegas MP, Davidoff A, Han X et al (2016) Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol 34(3):259–267PubMedCrossRef Yabroff KR, Dowling EC, Guy GP Jr, Banegas MP, Davidoff A, Han X et al (2016) Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol 34(3):259–267PubMedCrossRef
27.
Zurück zum Zitat Wheeler SB, Spencer JC, Pinheiro LC, Carey LA, Olshan AF, Reeder-Hayes KE (2018) Financial impact of breast cancer in black versus white women. J Clin Oncol 36(17):1695–1701PubMedPubMedCentralCrossRef Wheeler SB, Spencer JC, Pinheiro LC, Carey LA, Olshan AF, Reeder-Hayes KE (2018) Financial impact of breast cancer in black versus white women. J Clin Oncol 36(17):1695–1701PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Ekwueme DU, Zhao J, Rim SH, de Moor JS, Zheng Z, Khushalani JS, Han X, Kent EE, Yabroff KR (2019) Annual out-of-pocket expenditures and financial hardship among cancer survivors aged 18–64 years—United States, 2011–2016. Morb Mortal Wkly Rep 68(22):494–499CrossRef Ekwueme DU, Zhao J, Rim SH, de Moor JS, Zheng Z, Khushalani JS, Han X, Kent EE, Yabroff KR (2019) Annual out-of-pocket expenditures and financial hardship among cancer survivors aged 18–64 years—United States, 2011–2016. Morb Mortal Wkly Rep 68(22):494–499CrossRef
29.
Zurück zum Zitat Murphy CC, Harlan LC, Warren JL, Geiger AM (2015) Race and insurance differences in the receipt of adjuvant chemotherapy among patients with stage III colon cancer. J Clin Oncol 33(23):2530–2536PubMedPubMedCentralCrossRef Murphy CC, Harlan LC, Warren JL, Geiger AM (2015) Race and insurance differences in the receipt of adjuvant chemotherapy among patients with stage III colon cancer. J Clin Oncol 33(23):2530–2536PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Karanth S, Fowler ME, Mao X, Wilson LE, Huang B, Pisu M et al (2019) Race, socioeconomic status, and health-care access disparities in ovarian cancer treatment and mortality: systematic review and meta-analysis. JNCI Cancer Spectrum 3(4):pkz084PubMedPubMedCentralCrossRef Karanth S, Fowler ME, Mao X, Wilson LE, Huang B, Pisu M et al (2019) Race, socioeconomic status, and health-care access disparities in ovarian cancer treatment and mortality: systematic review and meta-analysis. JNCI Cancer Spectrum 3(4):pkz084PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Krimphove MJ, Cole AP, Fletcher SA, Harmouch SS, Berg S, Lipsitz SR et al (2019) Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer. Prostate Cancer Prostatic Dis 22(1):125–136PubMedCrossRef Krimphove MJ, Cole AP, Fletcher SA, Harmouch SS, Berg S, Lipsitz SR et al (2019) Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer. Prostate Cancer Prostatic Dis 22(1):125–136PubMedCrossRef
32.
Zurück zum Zitat Knight TG, Deal AM, Dusetzina SB, Muss HB, Choi SK, Bensen JT, Williams GR (2018) Financial toxicity in adults with cancer: adverse outcomes and noncompliance. J Oncol Pract 14(11):e665–e673CrossRef Knight TG, Deal AM, Dusetzina SB, Muss HB, Choi SK, Bensen JT, Williams GR (2018) Financial toxicity in adults with cancer: adverse outcomes and noncompliance. J Oncol Pract 14(11):e665–e673CrossRef
33.
Zurück zum Zitat Rim SH, Guy GP Jr, Yabroff KR, McGraw KA, Ekwueme DU (2016) The impact of chronic conditions on the economic burden of cancer survivorship: a systematic review. Exp Rev Pharmacoecon Outcomes Res 16(5):579–589CrossRef Rim SH, Guy GP Jr, Yabroff KR, McGraw KA, Ekwueme DU (2016) The impact of chronic conditions on the economic burden of cancer survivorship: a systematic review. Exp Rev Pharmacoecon Outcomes Res 16(5):579–589CrossRef
34.
Zurück zum Zitat Weaver KE, Rowland JH, Bellizzi KM, Aziz NM (2010) Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer 116(14):3493–3504PubMedCrossRef Weaver KE, Rowland JH, Bellizzi KM, Aziz NM (2010) Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer 116(14):3493–3504PubMedCrossRef
35.
Zurück zum Zitat Banegas MP, Guy GP Jr, de Moor JS, Ekwueme DU, Virgo KS, Kent EE, Nutt S, Zheng Z, Rechis R, Yabroff KR (2016) For working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff 35(1):54–61CrossRef Banegas MP, Guy GP Jr, de Moor JS, Ekwueme DU, Virgo KS, Kent EE, Nutt S, Zheng Z, Rechis R, Yabroff KR (2016) For working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff 35(1):54–61CrossRef
36.
Zurück zum Zitat Ramsey S, Blough D, Kirchhoff A, Kreizenbeck K, Fedorenko C, Snell K, Newcomb P, Hollingworth W, Overstreet K (2013) Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff 32(6):1143–1152CrossRef Ramsey S, Blough D, Kirchhoff A, Kreizenbeck K, Fedorenko C, Snell K, Newcomb P, Hollingworth W, Overstreet K (2013) Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff 32(6):1143–1152CrossRef
37.
Zurück zum Zitat Shankaran V, Jolly S, Blough D, Ramsey SD (2012) Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol 30(14):1608–1614PubMedCrossRef Shankaran V, Jolly S, Blough D, Ramsey SD (2012) Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol 30(14):1608–1614PubMedCrossRef
38.
Zurück zum Zitat Azzani M, Roslani AC, Su TT (2015) The perceived cancer-related financial hardship among patients and their families: a systematic review. Support Care Cancer 23(3):889–898PubMedCrossRef Azzani M, Roslani AC, Su TT (2015) The perceived cancer-related financial hardship among patients and their families: a systematic review. Support Care Cancer 23(3):889–898PubMedCrossRef
39.
Zurück zum Zitat Tucker-Seeley RD, Yabroff KR (2016) Minimizing the “financial toxicity” associated with cancer care: advancing the research agenda. JNCI: J Natl Cancer Instit 108(5):djv410CrossRef Tucker-Seeley RD, Yabroff KR (2016) Minimizing the “financial toxicity” associated with cancer care: advancing the research agenda. JNCI: J Natl Cancer Instit 108(5):djv410CrossRef
40.
Zurück zum Zitat Gany FM, Shah SM, Changrani J (2006) New York City’s immigrant minorities: reducing cancer health disparities. Cancer 107(S8):2071–2081PubMedCrossRef Gany FM, Shah SM, Changrani J (2006) New York City’s immigrant minorities: reducing cancer health disparities. Cancer 107(S8):2071–2081PubMedCrossRef
41.
Zurück zum Zitat Gordon LG, Merollini KM, Lowe A, Chan RJ (2017) A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. Patient Patient-Cent Outcomes Res 10(3):295–309CrossRef Gordon LG, Merollini KM, Lowe A, Chan RJ (2017) A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. Patient Patient-Cent Outcomes Res 10(3):295–309CrossRef
42.
Zurück zum Zitat Yabroff KR, Zhao J, Zheng Z, Rai A, Han X (2018) Medical financial hardship among cancer survivors in the United States: what do we know? What do we need to know? Cancer Epidemiol Prevent Biomark 27(12):1389–1397CrossRef Yabroff KR, Zhao J, Zheng Z, Rai A, Han X (2018) Medical financial hardship among cancer survivors in the United States: what do we know? What do we need to know? Cancer Epidemiol Prevent Biomark 27(12):1389–1397CrossRef
44.
Zurück zum Zitat Himmelstein, D. U., Lawless, R. M., Thorne, D., Foohey, P., & Woolhandler, S. (2019). Medical bankruptcy: still common despite the Affordable Care Act. Himmelstein, D. U., Lawless, R. M., Thorne, D., Foohey, P., & Woolhandler, S. (2019). Medical bankruptcy: still common despite the Affordable Care Act.
46.
Zurück zum Zitat Johnson M, Kishore S, Berwick DM (2020) Medicare for All: an analysis of key policy issues: a discussion of design issues and options raised by pending Medicare for All legislation and proposals. Health Aff 39(1):133–141CrossRef Johnson M, Kishore S, Berwick DM (2020) Medicare for All: an analysis of key policy issues: a discussion of design issues and options raised by pending Medicare for All legislation and proposals. Health Aff 39(1):133–141CrossRef
47.
Zurück zum Zitat Blinder VS, Gany FM (2020) Impact of cancer on employment. J Clin Oncol Off J Am Soc Clin Oncol 38(4):302–309CrossRef Blinder VS, Gany FM (2020) Impact of cancer on employment. J Clin Oncol Off J Am Soc Clin Oncol 38(4):302–309CrossRef
48.
Zurück zum Zitat Gibson M, Hearty W, Craig P (2020) The public health effects of interventions similar to basic income: a scoping review. Lancet Public Health 5(3):e165–e176 Gibson M, Hearty W, Craig P (2020) The public health effects of interventions similar to basic income: a scoping review. Lancet Public Health 5(3):e165–e176
Metadaten
Titel
The financial coping strategies of US cancer patients and survivors
verfasst von
Meredith Doherty
Daniel Gardner
Jackie Finik
Publikationsdatum
18.03.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 10/2021
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06113-z

Weitere Artikel der Ausgabe 10/2021

Supportive Care in Cancer 10/2021 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.